Abstract
During the past several decades, an increasing incidence of thyroid cancer has been reported in many parts of the world. To date, no study has compared the trends in thyroid cancer incidence across continents. We examined incidence data from cancer incidence in five continents (CI5) over the 30-year period 1973–2002 from 19 populations in the Americas, Asia, Europe, and Oceania. Thyroid cancer rates have increased from 1973–1977 to 1998–2002 for most of the populations except Sweden, in which the incidence rates decreased about 18% for both males and females. The average increase was 48.0% among males and 66.7% among females. More recently, the age-adjusted international thyroid cancer incidence rates from 1998 to 2002 varied 5-fold for males and nearly 10-fold for females by geographic region. Considerable variation in thyroid cancer incidence was present for every continent but Africa, in which the incidence rates were generally low. Our analysis of published CI5 data suggests that thyroid cancer rates increased between 1973 and 2002 in most populations worldwide, and that the increase does not appear to be restricted to a particular region of the world or by the underlying rates of thyroid cancer.
Similar content being viewed by others
References
Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (eds) (2007) Cancer incidence in five continents, vol IX. IARC Scientific Publications, Lyon, IARC, p 160
Akslen LA, Haldorsen T, Thoresen SO, Glattre E (1993) Incidence pattern of thyroid cancer in Norway: influence of birth cohort and time period. Int J Cancer 53:183–187. doi:10.1002/ijc.2910530202
Colonna M, Grosclaude P, Remontet L et al (2002) Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Eur J Cancer 38:1762–1768. doi:10.1016/S0959-8049(02)00110-7
Dos Santos Silva I, Swerdlow AJ (1993) Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer 67:330–340
Montanaro F, Pury P, Bordoni A, Lutz JM (2006) Unexpected additional increase in the incidence of thyroid cancer among a recent birth cohort in Switzerland. Eur J Cancer Prev 15:178–186. doi:10.1097/01.cej.0000197450.94980.36
Pettersson B, Adami HO, Wilander E, Coleman MP (1991) Trends in thyroid cancer incidence in Sweden, 1958–1981, by histopathologic type. Int J Cancer 48:28–33
Qian B, He M, Dong S, Wang J, Chen K (2005) Incidence and mortality of thyroid cancers in Tianjin from 1981 to 2001. Chin J Endocrinol Metab 21:432–434
Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167. doi:10.1001/jama.295.18.2164
Surveillance, Epidemiology, and End Results (SEER) Program (November 2007 submission). Public-use database (1973–2005). National Cancer Institute DCCPS, Suveillance Research Program, Cancer Statistics Branch, Released April 2008, based on the November 2007 submission
World Health Organization (1998) In: Hedinger CWE, Sobin LH (eds) Histological typing of thyroid tumours, 2nd edn. Springer, Berlin
LiVolsi VA, Asa SL (1994) The demise of follicular carcinoma of the thyroid gland. Thyroid 4:233–236
Delange F, Lecomte P (2003) Iodine supplementation: benefits outweigh risk. Drug Saf 22:89–95. doi:10.2165/00002018-200022020-00001
Harach HR (2003) Sporadic versus familial medullary thyroid microcarcinoma. Am J Surg Pathol 27:136–137. doi:10.1097/00000478-200301000-00016
Huszno B, Szybinski Z, Przybylik-Mazurek E, Stachura J, Trofimiuk M, Buziak-Bereza M, Gollowski F, Pantoflinski J (2003) Incidence of thyroid cancer in the selected areas of iodine deficiency in Poland. J Endocrinol Invest 26:57–62
World Health Organization (2004). In: de Benoist B, Andersson M, Egli I, Takkouche B, Allen H (eds). Iodine status worldwide: WHO global database on iodine deficiency. Department of Nutrition for Health and Development. World Health Organization, Geneva
Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. Version 2.0. IARC Press, Lyon
Zhang Y, Guo G, Han X, Zhu C, Kilfoy BA, Zhu Y, Boyle P, Zheng T (2008) Do polybrominated diphenyl ethers (PBDEs) increase the risk of thyroid cancer? Biosci Hypothesis 1:195–199. doi:10.1016/j.bihy.2008.06.003
Schecter A, Päpke O, Tung KC, Joseph J, Harris TR, Dahlgren J (2005) Polybrominated diphenyl ether flame retardants in the U.S. population: current levels, temporal trends, and comparison with dioxins, dibenzofurans, and polychlorinated biphenyls. J Occup Environ Med 47(3):199–211. doi:10.1097/01.jom.0000158704.27536.d2 Mar
Guvenius DM, Aronsson A, Ekman-Ordeberg G, Bergman A, Noren K (2003) Human prenatal and postnatal exposure to polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorobiphenylols, and pentachlorophenol. Environ Health Perspect 111:1235–1241
Directive 2003/11/EC of the European Parliament and of the Council of 6 February 2003 amending for the 24th time Council Directive 76/769/EEC relating to restrictions on the marketing and use of certain dangerous substances and preparations (pentabromodiphenyl ether, octabromodiphenylether). http://eur-x.europa.eu/LexUriServ/site/en/oj/2003/l_042/l_04220030215en00450046.pdf
“Chemical ban puts industry on the defensive.” State of Washington bans use of PBDEs. http://seattlepi.nwsource.com/local/311845_pbdes17.html
Memon A, Darif M, Al-Saleh K, Suresh A (2002) Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case–control study in the Middle East. Int J Cancer 97:82–89. doi:10.1002/ijc.1573
Negri E, Dal Maso L, Ron E et al (1999) A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 10:143–155. doi:10.1023/A:1008880429862
Zivaljevic V, Vlajinac H, Jankovic R et al (2003) Case–control study of female thyroid cancer—menstrual, reproductive and hormonal factors. Eur J Cancer Prev 12:63–66. doi:10.1097/00008469-200302000-00010
Goodman MT, Kolonel LN, Wilkens LR (1992) The association of body size, reproductive factors and thyroid cancer. Br J Cancer 66:1180–1184
Smith P, Williams ED, Wynford-Thomas D (1987) In vitro demonstration of a TSH-specific growth desensitising mechanism in rat thyroid epithelium. Mol Cell Endocrinol 51:51–58. doi:10.1016/0303-7207(87)90118-3
Acknowledgment
This research was supported by the National Institutes of Health training grant TU2CA105666 and National Institutes of Health Fogarty training grant 2043TW007864-01.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kilfoy, B.A., Zheng, T., Holford, T.R. et al. International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20, 525–531 (2009). https://doi.org/10.1007/s10552-008-9260-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-008-9260-4